Observational Prospectif Monocentric Registry of Patients Suffering From VIE

University Hospital, Strasbourg, France300 enrolled

Overview

Patients with an episode of VTE (DVT and / or PE) have a mortality rate of 16-21% at 1 year after diagnosis. Morbidity associated with VTE is marked by the risk of recurrence, estimated at 30% and estimated at 29% after 8 years of follow post-thrombotic syndrome. For a number of these patients, risk factors have been identified (congenital or acquired thrombophilia, cancer, postpartum, surgery, prolonged immobilization, etc..). In 25-50% of cases, the etiology remains unknown, justifying the need for well-conducted studies to determine other potential risk factors. In addition, the expansion of treatment options with the arrival on the market of new direct oral anticoagulants, allows comparative studies on the effectiveness and frequency of adverse events for each treatment.

Study Type

OBSERVATIONAL

Enrollment

300

Conditions

Venous Thromboembolic Disease

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * diagnosis of venous thromboembolism established by a validated test (venous Doppler ultrasound of the lower limbs, pulmonary angiography, lung scan ventilation / perfusion), * diagnosis of venous thromboembolism made within 15 days, * the previous inclusion in the register (outpatient or inpatient) Exclusion Criteria: * person doesn't wish to participate in this study

Locations (1)

Service Des Maladies Vasculaires - Hta - Nhc

Outcomes

Primary Outcomes

incidence of recurrent thromboembolic

Time frame: at 1 year post-diagnosis

bleeding complications incidence

Time frame: at 1 year post-diagnosis